1. Home
  2. LSTA vs NDLS Comparison

LSTA vs NDLS Comparison

Compare LSTA & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • NDLS
  • Stock Information
  • Founded
  • LSTA 1980
  • NDLS 1995
  • Country
  • LSTA United States
  • NDLS United States
  • Employees
  • LSTA N/A
  • NDLS N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • NDLS Restaurants
  • Sector
  • LSTA Health Care
  • NDLS Consumer Discretionary
  • Exchange
  • LSTA Nasdaq
  • NDLS Nasdaq
  • Market Cap
  • LSTA 31.2M
  • NDLS 34.3M
  • IPO Year
  • LSTA N/A
  • NDLS 2013
  • Fundamental
  • Price
  • LSTA $2.61
  • NDLS $1.50
  • Analyst Decision
  • LSTA Strong Buy
  • NDLS Strong Buy
  • Analyst Count
  • LSTA 1
  • NDLS 2
  • Target Price
  • LSTA $15.00
  • NDLS $3.00
  • AVG Volume (30 Days)
  • LSTA 66.3K
  • NDLS 355.5K
  • Earning Date
  • LSTA 02-27-2025
  • NDLS 03-06-2025
  • Dividend Yield
  • LSTA N/A
  • NDLS N/A
  • EPS Growth
  • LSTA N/A
  • NDLS N/A
  • EPS
  • LSTA N/A
  • NDLS N/A
  • Revenue
  • LSTA N/A
  • NDLS $495,817,000.00
  • Revenue This Year
  • LSTA N/A
  • NDLS $0.24
  • Revenue Next Year
  • LSTA N/A
  • NDLS $0.19
  • P/E Ratio
  • LSTA N/A
  • NDLS N/A
  • Revenue Growth
  • LSTA N/A
  • NDLS N/A
  • 52 Week Low
  • LSTA $2.19
  • NDLS $0.55
  • 52 Week High
  • LSTA $4.20
  • NDLS $2.68
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 42.17
  • NDLS 68.95
  • Support Level
  • LSTA $2.45
  • NDLS $1.30
  • Resistance Level
  • LSTA $2.74
  • NDLS $1.73
  • Average True Range (ATR)
  • LSTA 0.32
  • NDLS 0.17
  • MACD
  • LSTA -0.05
  • NDLS 0.02
  • Stochastic Oscillator
  • LSTA 16.48
  • NDLS 73.26

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.

Share on Social Networks: